Cargando…
Sclerostin: Current Knowledge and Future Perspectives
In recent years study of rare human bone disorders has led to the identification of important signaling pathways that regulate bone formation. Such diseases include the bone sclerosing dysplasias sclerosteosis and van Buchem disease, which are due to deficiency of sclerostin, a protein secreted by o...
Autores principales: | Moester, M. J. C., Papapoulos, S. E., Löwik, C. W. G. M., van Bezooijen, R. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903685/ https://www.ncbi.nlm.nih.gov/pubmed/20473488 http://dx.doi.org/10.1007/s00223-010-9372-1 |
Ejemplares similares
-
Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
por: van Bezooijen, Rutger L., et al.
Publicado: (2004) -
Sclerostin Inhibition in the Management of Osteoporosis
por: Appelman-Dijkstra, Natasha M., et al.
Publicado: (2016) -
Sclerostin
por: Silverman, Stuart L.
Publicado: (2010) -
Galectins in Esophageal Cancer: Current Knowledge and Future Perspectives
por: Godefa, Tesfay M., et al.
Publicado: (2022) -
Almond Anthracnose: Current Knowledge and Future Perspectives
por: López-Moral, Ana, et al.
Publicado: (2020)